Article
Criteria to define HLA haplotype loss in human solid tumors.
Tissue antigens - 1 May 2000
Ramal L M, Feenstra M, van der Zwan A W, Collado A, Lopez-Nevot M A, Tilanus M, Garrido F
Abstract excerpt
Short tandem repeat (STR) markers are currently used to define loss of heterozygosity (LOH) of genes and chromosomes in tumors. Chromosome 6 and chromosome 15 STR markers are applied to define loss of HLA and related genes (e.g. TAP and beta2m). The number of STR identified in the HLA region is still increasing. In this study, seven representative STR markers covering the 6p/6q arms of chromosome 6 including the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
